- Home
- HIMX vs DYN Comparison
HIMX vs DYN Comparison
Compare HIMX & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIMX
- DYN
- Stock Information
- Founded
- HIMX 2001
- DYN 1984
- Country
- HIMX Taiwan
- DYN United States
- Employees
- HIMX N/A
- DYN N/A
- Industry
- HIMX Semiconductors
- DYN Medicinal Chemicals and Botanical Products
- Sector
- HIMX Technology
- DYN Health Care
- Exchange
- HIMX Nasdaq
- DYN Nasdaq
- Market Cap
- HIMX 1.5B
- DYN 1.4B
- IPO Year
- HIMX 2006
- DYN 2020
- Fundamental
- Price
- HIMX $8.95
- DYN $8.67
- Analyst Decision
- HIMX Buy
- DYN Strong Buy
- Analyst Count
- HIMX 1
- DYN 15
- Target Price
- HIMX $15.00
- DYN $43.60
- AVG Volume (30 Days)
- HIMX 1.4M
- DYN 3.1M
- Earning Date
- HIMX 08-07-2025
- DYN 08-11-2025
- Dividend Yield
- HIMX 4.13%
- DYN N/A
- EPS Growth
- HIMX 87.58
- DYN N/A
- EPS
- HIMX 0.50
- DYN N/A
- Revenue
- HIMX $914,385,000.00
- DYN N/A
- Revenue This Year
- HIMX N/A
- DYN N/A
- Revenue Next Year
- HIMX $7.15
- DYN N/A
- P/E Ratio
- HIMX $17.90
- DYN N/A
- Revenue Growth
- HIMX 0.62
- DYN N/A
- 52 Week Low
- HIMX $5.12
- DYN $6.36
- 52 Week High
- HIMX $13.91
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- HIMX 53.06
- DYN 28.24
- Support Level
- HIMX $8.58
- DYN $10.00
- Resistance Level
- HIMX $9.82
- DYN $10.74
- Average True Range (ATR)
- HIMX 0.39
- DYN 0.81
- MACD
- HIMX -0.04
- DYN -0.46
- Stochastic Oscillator
- HIMX 33.59
- DYN 5.35
About HIMX Himax Technologies Inc.
Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue is derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.